Auriga Starts Protalix BioTherapeutics (PLX) at Buy
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.17 +0.46%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Auriga initiates coverage on Protalix BioTherapeutics (NYSE: PLX) with a Buy. PT $8.00.
For an analyst ratings summary and ratings history on Protalix BioTherapeutics click here. For more ratings news on Protalix BioTherapeutics click here.
Shares of Protalix BioTherapeutics closed at $5.85 yesterday.
For an analyst ratings summary and ratings history on Protalix BioTherapeutics click here. For more ratings news on Protalix BioTherapeutics click here.
Shares of Protalix BioTherapeutics closed at $5.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds Banking Group Plc. (LLOY:LN) (LYG) at Hold
- CLSA Starts Vedanta Aluminium Metal (VAML:IN) at Outperform (2)
- Goldman Sachs Starts Treasury Wine Estates Ltd. (TWE:AU) (TSRYY) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
